Log in
Enquire now
‌

US Patent 11248054 Anti-IL1RAP antibodies and antibody drug conjugates

Patent 11248054 was granted and assigned to Bluefin Biomedicine on February, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
‌
Bluefin Biomedicine
Current Assignee
‌
Bluefin Biomedicine
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11248054
Date of Patent
February 15, 2022
Patent Application Number
16620386
Date Filed
June 12, 2018
Patent Citations
‌
US Patent 10471086 Treatment of chronic obstructive pulmonary disease (COPD)
‌
US Patent 10519230 Nucleic acids encoding IL-33 antibodies
‌
US Patent 10544212 Anti-IL-33 antibodies, compositions, methods and uses thereof
‌
US Patent 10562971 Method of detection of IL1RAP on cells expressing the protein
‌
US Patent 10588298 Humanized IL-4 and IL-4Rα animals
‌
US Patent 10668150 IL33 form, mutated forms of IL33, antibodies, assays and methods of using the same
‌
US Patent 10669594 Compositions and methods for detecting a biological contaminant
‌
US Patent 10723795 Anti-interleukin-33 antibodies and uses thereof
...
Patent Primary Examiner
‌
Elly-Gerald Stoica
Patent abstract

Disclosed herein are Interleukin 1 Receptor Accessory Protein (IL1RAP) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11248054 Anti-IL1RAP antibodies and antibody drug conjugates

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.